Denver, CO (PRWEB) September 27, 2012
The Yaz Resource Center, a patient advocacy group, is alerting women who suffered a blood clot after taking the birth control drugs Yaz or Yasmin that the manufacturer, Bayer, has started settling injury claims. However, only certain claims may qualify and the time to file is limited.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.
The British Medical Journal published a study from the University of Copenhagen on October 25, 2011 which linked the hormone in Yaz to blood clots. On October 27, 2011, the FDA released its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" showing drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
Due to the number of patients that have filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the cases. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 10,000 patients have filed a claim.
According to Bloomberg News on July 31st, Bayer has begun settling Yaz lawsuits, with as many as 1900 resolved so far. They have also reserved up to $610 million to dispense the cases at an average of around $212,000.
On July 11, 2012, The Madison Record also reported that Stephen Saltzburg, the special master appointed to oversee settlement negotiations for the federal MDL court, estimated Yaz lawsuit negotiations could be concluded within a year.
The news of Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited and only certain cases may qualify. Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible.
The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.